Investor Presentation • Nov 6, 2025
Investor Presentation
Open in ViewerOpens in native device viewer

November 2025

2
This presentation may contain "forward-looking statements," which include information concerning Celanese Corporation's (the "Company") plans objectives, goals, strategies, future revenues, cash flow, financial performance, synergies, capital expenditures, deleveraging efforts, planned cost reductions, dividend policy, financing needs and other information that is not historical information. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the results expressed or implied in the forward-looking statements contained in this presentation. These risks and uncertainties include, among other things: the ability to successfully achieve planned cost reductions; changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate; the length and depth of product and industry business cycles, particularly in the automotive, electrical, textiles, electronics and construction industries; volatility or changes in the price and availability of raw materials and energy, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, carbon monoxide, wood pulp, hexamethylene diamine, Polyamide 66 ("PA66"), polybutylene terephthalate, ethanol, natural gas and fuel oil, and the prices for electricity and other energy sources; the ability to pass increases in raw materials prices, logistics costs and other costs on to customers or otherwise improve margins through price increases; the possibility that we will not be able to realize the anticipated benefits of the Mobility & Materials business (the "M&M Business") we acquired from DuPont de Nemours, Inc. (the "M&M Acquisition"), including synergies and growth opportunities, whether as a result of difficulties arising from the operation of the M&M Business or other unanticipated delays, costs, inefficiencies or liabilities; additional impairments of goodwill or intangible assets; increased commercial, legal or regulatory complexity of entering into, or expanding our exposure to, certain end markets and geographies; risks in the global economy and equity and credit markets and their potential impact on our ability to pay down debt in the future and/or refinance at suitable rates, in a timely manner, or at all; risks and costs associated with increased leverage from the M&M Acquisition, including increased interest expense and potential reduction of business and strategic flexibility; the ability to maintain plant utilization rates and to implement planned capacity additions, expansions and maintenance; the ability to reduce or maintain current levels of production costs and to improve productivity by implementing technological improvements to existing plants; increased price competition and the introduction of competing products by other companies; the ability to identify desirable potential acquisition or divestiture opportunities and to complete such transactions, including obtaining regulatory approvals, consistent with the Company's strategy; market acceptance of our products and technology; compliance and other costs and potential disruption or interruption of production or operations due to accidents, interruptions in sources of raw materials, transportation, logistics or supply chain disruptions, cybersecurity incidents, terrorism or political unrest, public health crises, or other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the direct or indirect consequences of acts of war or conflict (such as the Russia-Ukraine conflict or conflicts in the Middle East) or terrorist incidents or as a result of weather, natural disasters, or other crises; the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to the Company; changes in applicable tariffs, duties and trade agreements, tax rates or legislation throughout the world including, but not limited to, anti-dumping and countervailing duties, adjustments, changes in estimates or interpretations or the resolution of tax examinations or audits that may impact recorded or future tax impacts and potential regulatory and legislative tax developments in the United States and other jurisdictions; changes in the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such intellectual property; potential liability for remedial actions and increased costs under existing or future environmental, health and safety regulations, including those relating to climate change or other sustainability matters; potential liability resulting from pending or future claims or litigation, including investigations or enforcement actions, or from changes in the laws, regulations or policies of governments or other governmental activities, in the countries in which we operate; our level of indebtedness, which could diminish our ability to raise additional capital to fund operations or limit our ability to react to changes in the economy or the chemicals industry, and the success of our deleveraging efforts, as well as any changes to our credit ratings; changes in currency exchange rates and interest rates; tax rates and changes thereto; and various other factors discussed from time to time in the Company's filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.
The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Historical results should not be taken as an indication of the results of operations to be reported for any future period. Pro forma financial information herein is preliminary and subject to change.
This document presents the Company's two business segments, Engineered Materials and Acetyl Chain.
This presentation, and statements made in connection with this presentation, may refer to non-GAAP financial measures. For more information on the non-GAAP financial measures used by the Company, including the most directly comparable GAAP financial measure for each non-GAAP financial measures used, including definitions and reconciliations of the differences between such non-GAAP financial measures and the comparable GAAP financial measures, please refer to the Non-US GAAP Financial Measures and Supplemental Information document available on our website, investors.celanese.com, under Financial Information/Non-GAAP Financial Measures.

Celanese Corporation

\$375 M
\$1.34
FREE CASH FLOW*
ADJUSTED EPS*
ADJUSTED EBIT* BY BUSINESS SEGMENT
\$200 M
\$187 M
ENGINEERED MATERIALS
ACETYL CHAIN
Q3 results reflects robust free cash flow* generation, resilient EM performance, and continued focus on self-help measures

Q4 2025 Outlook
~ \$0.85 - \$1.00
ADJUSTED EPS* GUIDE
ADJUSTED EBIT* GUIDANCE BY BUSINESS SEGMENT
\$165 M – \$175 M
\$165 M – \$180 M
ENGINEERED MATERIALS
ACETYL CHAIN




INTENSIFY COST IMPROVEMENT
DRIVE TOP LINE GROWTH
to deleverage the balance sheet
by maximizing productivity every day
through supercharging the pipeline & strategic opportunities
Continue to aggressively execute against key priorities

"The Micromax divestiture further demonstrates our commitment to generate shareholder value by aggressively and prudently deleveraging our balance sheet.
This is an important milestone in our journey as we continue to execute against our key priorities."
Scott Richardson CEO and President




* Represents a non-GAAP measure. For information on historical non-GAAP financial measures used by the Company, including definitions and reconciliations to comparable GAAP financial measures, please refer to the Non-US GAAP Financial Measures and Supplemental Information document available on our website, investors.celanese.com, under Financial Information/Non-GAAP Financial Measures. 1. Based on midpoint of expected 2025 free cash flow range and market capitalization as of November 5, 2025


Opportunistic and prudent refinancing to align with maturities

Continually optimize blended borrowing cost across all debt

Maintain ample liquidity Excess cash + \$1.75 B revolver (currently undrawn)

Maintain flexibility via prepayable / callable debt

1As of September 30, 2025
Accelerating cash flow capabilities and strategic divestitures...

... increasingly deployed to deleveraging


* Represents a non-GAAP measure. For information on historical non-GAAP financial measures used by the Company, including definitions and reconciliations to comparable GAAP financial measures, please refer to the Non-US GAAP Financial Measures and Supplemental Information document available on our website, investors.celanese.com, under Financial Information/Non-GAAP Financial Measures.

Near Term Cost Reductions
\$80 - \$100 million
of targeted annualized savings primarily through headcount reduction


Engineered Materials Complexity Reduction \$50 - \$100 million
of targeted annualized savings primarily through distribution network improvements, footprint actions, and SG&A


Targeted Productivity
Ongoing
AC plant and distribution productivity in 2025 and evaluation of additional opportunities

2025 Expected In-Year Realization: \$120 M
Cost reductions are helping to set a firm foundation for long-term growth


Celanese continues to intensify cost reductions while aligning footprint with demand dynamics

Acetyls chemistry supports everyday life








Redispersible powders and emulsion dispersions are essential additives for construction applications




HIGH POLYMERS
PERFORMANCE
ENGINEERING POLYMERS
ELASTOMERS BIO POLYMERS Vectra® | Zenite®
Fortron®
Frianyl® XT | Celanyl® XT | Zytel®
Thermx®
Zytel®
Frianyl® | Celanyl® | Zytel®
Impet® | Rynite® | Mylar® | Melinex®
Celanex® | Vandar® | Crastin®
Hostaform® | Celcon® | Amcel®
Celstran®
GUR®
Polifor® | Talcoprene® | Tecnoprene®
Ateva® | VitalDose®
Vamac®
Hytrel®
Santoprene®
Laprene® | Sofprene®
Clarifoil®

✓ Intelligent search platform enabling selection of material solution for specific requirements

✓ Certified experts to accelerate design consultation, prototyping, simulation

✓ Support trials, training and optimizing process conditions

✓ Predict part performance in real-life




AUTOMOTIVE AND AUTONOMOUS MOBILITY



ELECTRIFICATION AND CONNECTIVITY



MEDICAL



FOOTWEAR DRONES NEOLAST

applications


Leadership driving change

Laser focused on deleveraging

Actions underway to deliver near-term earnings improvement

History of innovation as customer solutions provider

Strong earnings leverage as demand recovers

Attractive valuation with upside potential for stock
Our mission is to position Celanese as a top quartile company for total shareholder return by delivering earnings growth in any environment



Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.